Published in Blood on April 01, 1998
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
TNF-induced signaling in apoptosis. J Clin Immunol (1999) 1.71
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol (2000) 1.54
A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med (1999) 1.22
Coupling heme and iron metabolism via ferritin H chain. Antioxid Redox Signal (2013) 1.08
A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals. Hepatology (2013) 1.06
Gene expression profiling in conjunction with physiological rescues of IKKalpha-null cells with wild type or mutant IKKalpha reveals distinct classes of IKKalpha/NF-kappaB-dependent genes. J Biol Chem (2005) 0.95
A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One (2011) 0.94
Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One (2013) 0.92
TNFalpha-induced macrophage death via caspase-dependent and independent pathways. Apoptosis (2009) 0.91
Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades. Proc Natl Acad Sci U S A (2005) 0.91
A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis (2010) 0.91
The role of A20 in the pathogenesis of lymphocytic malignancy. Cancer Cell Int (2012) 0.87
The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Transplant Proc (2006) 0.85
Inhibitive effect of purple sweet potato leaf extract and its components on cell adhesion and inflammatory response in human aortic endothelial cells. Cell Adh Migr (2013) 0.85
Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. J Neural Transm (Vienna) (2006) 0.84
A20 deficiency causes spontaneous neuroinflammation in mice. J Neuroinflammation (2014) 0.82
A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis. Transplantation (2012) 0.81
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80
Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis. J Immunol Res (2014) 0.80
Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model. Transplantation (2012) 0.80
Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol (2012) 0.79
Role of A20 in cIAP-2 protection against tumor necrosis factor α (TNF-α)-mediated apoptosis in endothelial cells. Int J Mol Sci (2014) 0.78
Intragraft gene expression profile associated with the induction of tolerance. BMC Immunol (2008) 0.78
The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells. Biochim Biophys Acta (2013) 0.77
NF-kappaB activation and zinc finger protein A20 expression in mature dendritic cells derived from liver allografts undergoing acute rejection. World J Gastroenterol (2003) 0.77
A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes. FASEB J (2015) 0.77
A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels. J Biol Chem (2014) 0.76
MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD. JCI Insight (2017) 0.75
A20 deficiency leads to angiogenesis of pulmonary artery endothelial cells through stronger NF-κB activation under hypoxia. J Cell Mol Med (2016) 0.75
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc (1973) 3.35
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Hu-1: Major histocompatibility locus in man. Science (1967) 3.13
Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04
Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM). Intensive Care Med (2012) 2.49
An encyclopedia of mouse genes. Nat Genet (1999) 2.48
Barriers to xenotransplantation. Nat Med (1995) 2.44
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem (1996) 2.26
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. J Exp Med (1974) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J Immunol Methods (1973) 1.97
Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. Cell Immunol (1970) 1.97
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
Determinants of measles mortality in a rural area of Guinea-Bissau: crowding, age, and malnutrition. J Trop Pediatr (1984) 1.79
A pathway for the evolution of the plasmid NTP16 involving the novel kanamycin resistance transposon Tn4352. Plasmid (1987) 1.79
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. Cell Immunol (1970) 1.74
Appropriateness of emergency department visits in a Portuguese university hospital. Ann Emerg Med (2001) 1.74
Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (1981) 1.72
Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med (1972) 1.70
Five HLA-D clusters associated with HLA-DR4. Hum Immunol (1982) 1.70
The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet (2001) 1.68
Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature (1976) 1.64
Specificity of allogeneic cell recognition by human lymphocytes in vitro. Science (1971) 1.62
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. Proc Natl Acad Sci U S A (1969) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59
A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.59
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56
Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors. Scand J Immunol (1975) 1.55
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
Genetic control of cell-mediated lympholysis in mouse. J Exp Med (1974) 1.51
TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol (1980) 1.50
Alternative pathways of T lymphocyte activation. J Exp Med (1978) 1.49
Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med (1996) 1.49
Call for moratorium on xenotransplants. Nature (1998) 1.48
Specificity of antigen recognition by human lymphocytes in vitro. Science (1970) 1.48
Continuous culture of T cells cytotoxic for autologous human leukaemia cells. Nature (1979) 1.46
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol (1973) 1.44
Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
Dw/LD-related molecular polymorphism of DR4 beta-chains. J Exp Med (1983) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature (1978) 1.41
Lung cancer in Northern Portugal: A hospital-based study. Rev Port Pneumol (2013) 1.40
SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature (1981) 1.40
Reflections on the recommendations of the EWMA Patient Outcome Group document. J Wound Care (2010) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Human lymphocytes recognise mouse alloantigens. Nature (1975) 1.31
Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem (1996) 1.30
Transplantation: pairing of donor and recipient. Science (1970) 1.28
Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem (1995) 1.26
Cytotoxicity: specificity after in vitro sensitization. Science (1970) 1.26
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol (1987) 1.26
Specificity of cell-mediated lympholysis for public and private H-2 determinants. Scand J Immunol (1975) 1.24
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem (1994) 1.24
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med (1990) 1.23
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med (1999) 1.22
Abrogation of cytotoxicity of mixed leukocyte cultures. Transplant Proc (1972) 1.21
Genetic control of mixed leukocyte culture reactivity. Transplant Rev (1972) 1.21
Lysis of leukemia cells by spleen cells of normal mice. Proc Natl Acad Sci U S A (1975) 1.20
Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol Biol (1999) 1.19
OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules. J Immunol (1984) 1.18
Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction. J Exp Med (1976) 1.16
Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. J Immunol (1983) 1.15
Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun (1998) 1.15